Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health.
Milligan Armstrong A, O'Brien E, Porter T, Dore V, Bourgeat P, Maruff P, Rowe CC, Villemagne VL, Rainey-Smith SR, Laws SM; AIBL Research Group. Milligan Armstrong A, et al. Among authors: maruff p. Alzheimers Dement (Amst). 2025 Jan 16;17(1):e70056. doi: 10.1002/dad2.70056. eCollection 2025 Jan-Mar. Alzheimers Dement (Amst). 2025. PMID: 39822292 Free PMC article.
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial.
Shanbhag NM, Padmanabhan JL, Zhang Z, Harel BT, Jia H, Kangarloo T, Yin W, Dowling AV, Laurenza A, Khudyakov P, Galinsky K, Latzman RD, Simuni T, Weintraub D, Horak FB, Lustig C, Maruff P, Simen AA. Shanbhag NM, et al. Among authors: maruff p. JAMA Neurol. 2025 Jan 6. doi: 10.1001/jamaneurol.2024.4519. Online ahead of print. JAMA Neurol. 2025. PMID: 39761063
Alzheimer's disease drug development in an evolving therapeutic landscape.
Weninger S, Irizarry MC, Fleisher AS, León T, Maruff P, Miller DS, Seleri S, Carrillo MC, Weber CJ. Weninger S, et al. Among authors: maruff p. Alzheimers Dement (N Y). 2024 Nov 30;10(4):e70015. doi: 10.1002/trc2.70015. eCollection 2024 Oct-Dec. Alzheimers Dement (N Y). 2024. PMID: 39748838 Free PMC article.
Evaluation of effect of cooled haemodialysis on cognition in patients with end-stage kidney disease (ECHECKED) feasibility randomised controlled trial results.
Dasgupta I, Odudu A, Baharani J, Fergusson N, Griffiths H, Harrison J, Hameed A, Maruff P, Ryan L, Thomas N, Woodhall G, Tadros G. Dasgupta I, et al. Among authors: maruff p. BMC Nephrol. 2024 Dec 19;25(1):466. doi: 10.1186/s12882-024-03883-6. BMC Nephrol. 2024. PMID: 39702060 Free PMC article. Clinical Trial.
Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies.
Morrison RL, Singh J, Daly E, Fedgchin M, Ochs-Ross R, Karcher K, Lane R, Cooper K, Sanacora G, Maruff P, Drevets WC. Morrison RL, et al. Among authors: maruff p. Int J Neuropsychopharmacol. 2024 Nov 1;27(11):pyae046. doi: 10.1093/ijnp/pyae046. Int J Neuropsychopharmacol. 2024. PMID: 39514643 Free PMC article. Clinical Trial.
Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.
Ayton S, Barton D, Brew B, Brodtmann A, Clarnette R, Desmond P, Devos D, Ellis KA, Fazlollahi A, Fradette C, Goh AMY, Kalinowski P, Kyndt C, Lai R, Lim YY, Maruff P, O'Brien TJ, Rowe C, Salvado O, Schofield PW, Spino M, Tricta F, Wagen A, Williams R, Woodward M, Bush AI. Ayton S, et al. Among authors: maruff p. JAMA Neurol. 2025 Jan 1;82(1):11-18. doi: 10.1001/jamaneurol.2024.3733. JAMA Neurol. 2025. PMID: 39495531 Clinical Trial.
532 results